Avidity of CD8 T cells sharpens immunodominance
スポンサーリンク
概要
- 論文の詳細を見る
- 2007-04-01
著者
-
Belyakov Igor
Molecular Immunogenetics And Vaccine Research Section Vaccine Branch Center For Cancer Research Nati
-
Belyakov Igor
Vaccine Branch Center For Cancer Research National Cancer Institute National Institutes Of Health
-
DZUTSEV Amiran
Vaccine Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health
-
ISAKOV Dmitry
Vaccine Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health
-
MARGULIES David
Laboratory of Immunology, National Institute of Allergy and Infectious Diseases, National Institutes
-
BERZOFSKY Jay
Vaccine Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health
-
Berzofsky J
Molecular Immunogenetics And Vaccine Research Section Vaccine Branch Center For Cancer Research Nati
-
Isakov Dmitry
Vaccine Branch Center For Cancer Research National Cancer Institute National Institutes Of Health
-
Berzofsky Jay
Vaccine Branch Center For Cancer Research National Cancer Institute National Institutes Of Health
-
Dzutsev Amiran
Vaccine Branch Center For Cancer Research National Cancer Institute National Institutes Of Health
-
Margulies David
Laboratory Of Immunology National Institute Of Allergy And Infectious Diseases National Institutes O
関連論文
- Avidity of CD8 T cells sharpens immunodominance
- Role of α3 domain of class I MHC molecules in the activation of high- and low-avidity CD8^+ CTLs
- Signals delivered through TCR instruct IL-12 receptor (IL-12R) expression : IL-12 and tumor necrosis factor-α synergize for IL-12R expression at low antigen dose
- Mechanisms of cytokine synergy essential for vaccine protection against viral challenge
- Counter-regulation of cytolytic activity and cytokine production in HIV-1-specific murine CD8^+ cytotoxic T lymphocytes by free antigenic peptide